Cardinal Health INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Valerie Christine Pitteroff, Chief Human Resources Officer of Cardinal Health Inc, received 2,610 shares of common stock on August 4, 2026.
NYSE
Mary C. Scherer, Chief Accounting Officer of Cardinal Health Inc, received 2,610 shares of common stock on August 4, 2026.
NYSE
Jessica L Mayer, Chief Legal/Compliance Officer of Cardinal Health Inc, received 46,992 shares of common stock on August 4, 2026.
NYSE
Stephen M Mason, CEO, GMPD Segment of Cardinal Health Inc, received 46,992 shares of common stock on August 4, 2026.
NYSE
Deborah Weitzman, CEO, PSS Segment of Cardinal Health Inc, received 54,823 shares of common stock on August 4, 2026.
NYSE
Aaron E Alt, Chief Financial Officer of Cardinal Health Inc, received 58,738 shares of common stock on August 4, 2026.
NYSE
Michelle D. Greene, Chief Information Officer of Cardinal Health Inc, received 17,230 shares of common stock on August 4, 2026.
NYSE
Director Patricia Hemingway Hall was granted 381 restricted stock units following her appointment as Chair of the Board.
NYSE
Cardinal Health's Chief Information Officer, Michelle D. Greene, sold 2,746 common shares for approximately $228.51 per share under a pre-arranged 10b5-1 plan.
NYSE
Cardinal Health's Chief Human Resources Officer, Valerie Christine Pitteroff, was granted 3,982 restricted share units valued at $213.26 per share.
NYSE
Cardinal Health's Chief Human Resources Officer, Ola M. Snow, disposed of 320 common shares to cover tax withholding obligations related to restricted share units.
NYSE
Cardinal Health's Chief Legal/Compliance Officer, Jessica L. Mayer, disposed of 422 common shares to cover tax withholding obligations related to restricted share units.
NYSE
Deborah Weitzman, CEO of Cardinal Health's PSS Segment, reported the withholding of 551 common shares to cover tax obligations related to restricted share units.
NYSE
Cardinal Health's Chief Accounting Officer, Mary C. Scherer, disposed of 61 common shares to cover tax withholding obligations related to restricted share units.
NYSE
Stephen M. Mason, CEO of Cardinal Health's GMPD Segment, disposed of 595 common shares to cover tax withholding obligations.
NYSE
Cardinal Health director Sudhakar Ramakrishna was granted 1,067 restricted share units, vesting in November 2026.
NYSE
Cardinal Health Inc. Director Robert W. Musslewhite was granted 1,067 restricted share units, vesting in November 2026.
NYSE
Cardinal Health Inc. Director Christine Mundkur was granted 1,067 restricted share units, vesting in November 2026.
NYSE
Cardinal Health director Nancy Killefer was granted 1,067 restricted share units, increasing her direct beneficial ownership to 27,624 common shares.
NYSE
Cardinal Health Director Gregory B. Kenny was granted 1,702 restricted share units, vesting in November 2026.
NYSE
Cardinal Health Inc. director Akhil Johri was granted 1,067 restricted share units, vesting in November 2026.
NYSE
Cardinal Health Director Patricia Hemingway Hall was granted 1,067 restricted share units, vesting in November 2026.
NYSE
Cardinal Health Director David C. Evans was granted 1,067 restricted share units, vesting in November 2026.
NYSE
Cardinal Health Director Sheri H. Edison was granted 1,067 restricted share units, increasing her beneficial ownership to 14,848 common shares.
NYSE
Cardinal Health director Michelle Brennan was granted 1,067 restricted share units, increasing her direct beneficial ownership to 8,086 common shares.
NYSE
Cardinal Health Director Robert Azelby was granted 1,067 restricted share units, vesting in November 2026, as reported in a recent SEC Form 4 filing.
NYSE
Cardinal Health's CEO of the PSS Segment, Deborah Weitzman, sold 21,367 common shares for approximately $3.2 million on August 20, 2025.
NYSE
Cardinal Health CEO Jason Hollar sold 35,901 common shares for approximately $5.4 million in pre-planned transactions.
NYSE
Cardinal Health's Chief Accounting Officer reported the sale of common shares and the acquisition of restricted share units.
NYSE
Cardinal Health's Chief Information Officer, Michelle D. Greene, reported the acquisition of restricted stock units and subsequent sales of common shares.